← Leaderboards
Michelle A T Hildebrandt
University Of Tx Md Anderson Can Ctr
$3,149,433
Attributed
$6,790,188
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,790,188 · 2
By mechanism
R01$6,790,188 · 2
Top collaborators
- Chad Daniel Huff5 shared
- Joellen M. Schildkraut5 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Chad Daniel Huff$10,145,666
- Francisco Vega-Vazquez$2,004,047
- Guang Peng$3,599,803
- Rebecca Maureen Howell$1,378,700
- Paul A Scheet$7,895,863
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisModalityMalignant NeoplasmsGeneticEthnic OriginEtiologyEuropeanBrca2 GeneEpithelialEarly DiagnosisAfricanAllelesAmericanAfrican AmericanBaseCancer RiskBrca2 MutationCancer CenterBurden Of IllnessChek2 GeneDna ResequencingBrca1 GeneBrca1 MutationCandidate Disease Gene
Grant awards (7)
Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors$636,638
R01 · FY2025 · CA · contact PI
Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors$692,417
R01 · FY2024 · CA · contact PI
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors$791,850
R01 · FY2019 · CA
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors$1,008,680
R01 · FY2018 · CA · contact PI
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors$1,225,214
R01 · FY2017 · CA · contact PI
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors$1,200,669
R01 · FY2016 · CA · contact PI
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors$1,234,720
R01 · FY2015 · CA · contact PI